This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Viñals, M. Articles by Badimon, L. Search for Related Content PubMed PubMed Citation Articles by Viñals, M. Articles by Badimon, L. Related Collections Growth factors/cytokines Smooth muscle proliferation and differentiation Lipid and lipoprotein metabolism Endothelium/vascular type/nitric oxide Mechanism of atherosclerosis/growth factors

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2405-2411.)
© 1999 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Regulatory Effects of HDL on Smooth Muscle Cell Prostacyclin Release

Marisa Viñals; José Martínez-González; Lina Badimon
Abstract—One mechanism by which high density lipoproteins (HDLs) exert their protective effect against coronary artery disease could be related to the induction of prostacyclin (PGI₂) release in the vessel wall. We have recently shown that HDL increases PGI₂ production in rabbit smooth muscle cells (RSMCs) and that this increase is dependent on cyclooxygenase-2 (Cox-2). Here we analyze the mechanism by which rabbit HDL induces PGI₂ release in RSMCs. Our results show that although HDL₂ and HDL₃ share a similar capacity to induce Cox-2 protein levels, HDL₃ stimulates a higher PGI₂ release than does HDL₂, probably because of their relative arachidonate contents. Acetylsalicylic acid pretreatment (300 µmol/L, 30 minutes) significantly reduced the HDL-induced PGI₂ release, suggesting that both preexisting and induced Cox-2 activities were involved in the HDL effect. Ca²⁺-dependent cytosolic phospholipase A₂ (cPLA₂) and Cox-1 protein levels were not altered by HDL. Dexamethasone (2 µmol/L), which also inhibited the HDL-induced PGI₂ release, reduced significantly both Cox-2 mRNA and protein levels without affecting cPLA₂ and Cox-1 protein levels. In addition, methylarachidonyl fluorophosphonate, a potent inhibitor of cPLA₂, did not produce any effect on HDL-induced PGI₂ release. In the presence of cycloheximide, Cox-2 mRNA levels were induced by HDL and inhibited by dexamethasone, suggesting that HDL and dexamethasone work in the absence of de novo protein synthesis. These results indicate an early effect of HDL on PGI₂ biosynthesis, specifically increasing Cox-2. PD98059, an inhibitor of mitogen-activated protein kinase kinase, completely inhibited HDL-induced PGI₂ release, whereas GF109203X, a protein kinase C inhibitor, had no effect. Thus, HDL induces PGI₂ synthesis by a mechanism dependent on the mitogen-activated protein kinase pathway but independent of protein kinase C.

Key Words: lipoproteins • cyclooxygenase-1 • cyclooxygenase-2 • cytosolic phospholipase A₂ • mitogen-activated protein kinases

This article has been cited by other articles:

				K. Sattler and B. Levkau Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection Cardiovasc Res, May 1, 2009; 82(2): 201 - 211. [Abstract] [Full Text] [PDF]

				J. Martinez-Gonzalez, R. Rodriguez-Rodriguez, M. Gonzalez-Diez, C. Rodriguez, M. D. Herrera, V. Ruiz-Gutierrez, and L. Badimon Oleanolic Acid Induces Prostacyclin Release in Human Vascular Smooth Muscle Cells through a Cyclooxygenase-2-Dependent Mechanism J. Nutr., March 1, 2008; 138(3): 443 - 448. [Abstract] [Full Text] [PDF]

				A. Damirin, H. Tomura, M. Komachi, M. Tobo, K. Sato, C. Mogi, H. Nochi, K. Tamoto, and F. Okajima Sphingosine 1-Phosphate Receptors Mediate the Lipid-Induced cAMP Accumulation through Cyclooxygenase-2/Prostaglandin I2 Pathway in Human Coronary Artery Smooth Muscle Cells Mol. Pharmacol., April 1, 2005; 67(4): 1177 - 1185. [Abstract] [Full Text] [PDF]

				M. Vinals, I. Bermudez, G. Llaverias, M. Alegret, R. M. Sanchez, M. Vazquez-Carrera, and J. C. Laguna Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages Cardiovasc Res, April 1, 2005; 66(1): 141 - 149. [Abstract] [Full Text] [PDF]

				G.D. Norata, E. Callegari, H. Inoue, and A.L. Catapano HDL3 Induces Cyclooxygenase-2 Expression and Prostacyclin Release in Human Endothelial Cells Via a p38 MAPK/CRE-Dependent Pathway: Effects on COX-2/PGI-Synthase Coupling Arterioscler Thromb Vasc Biol, May 1, 2004; 24(5): 871 - 877. [Abstract] [Full Text]

				G. Rossoni, M. Gomaraschi, F. Berti, C. R. Sirtori, G. Franceschini, and L. Calabresi Synthetic High-Density Lipoproteins Exert Cardioprotective Effects in Myocardial Ischemia/Reperfusion Injury J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 79 - 84. [Abstract] [Full Text] [PDF]

				L. Calabresi, M. Gomaraschi, and G. Franceschini Endothelial Protection by High-Density Lipoproteins: From Bench to Bedside Arterioscler Thromb Vasc Biol, October 1, 2003; 23(10): 1724 - 1731. [Abstract] [Full Text] [PDF]

				L. Calabresi, G. Rossoni, M. Gomaraschi, F. Sisto, F. Berti, and G. Franceschini High-Density Lipoproteins Protect Isolated Rat Hearts From Ischemia-Reperfusion Injury by Reducing Cardiac Tumor Necrosis Factor-{alpha} Content and Enhancing Prostaglandin Release Circ. Res., February 21, 2003; 92(3): 330 - 337. [Abstract] [Full Text] [PDF]

				A. Tedgui and Z. Mallat Anti-Inflammatory Mechanisms in the Vascular Wall Circ. Res., May 11, 2001; 88(9): 877 - 887. [Abstract] [Full Text] [PDF]